These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7594427)

  • 21. Chronic treatment with the angiotensin I converting enzyme inhibitor, perindopril, protects in vitro carbachol-induced vasorelaxation in a rat model of vascular calcium overload.
    Henrion D; Chillon JM; Capdeville-Atkinson C; Vinceneux-Feugier M; Atkinson J
    Br J Pharmacol; 1991 Dec; 104(4):966-72. PubMed ID: 1667295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced slow-pressor response to angiotensin II in spontaneously hypertensive rats.
    Li P; Jackson EK
    J Pharmacol Exp Ther; 1989 Dec; 251(3):909-21. PubMed ID: 2557422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin inhibits mesenteric vascular hypertrophy in angiotensin II-infusion hypertension in rats.
    Dilley RJ; Nataatmadja MI
    Cardiovasc Res; 1998 Apr; 38(1):247-55. PubMed ID: 9683928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.
    Chauvin B; Richer C; Giudicelli JF
    Br J Pharmacol; 1995 Oct; 116(4):2229-36. PubMed ID: 8564253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats.
    Stegbauer J; Oberhauser V; Vonend O; Rump LC
    Cardiovasc Res; 2004 Feb; 61(2):352-9. PubMed ID: 14736552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
    Otsuka S; Sugano M; Makino N; Sawada S; Hata T; Niho Y
    Hypertension; 1998 Sep; 32(3):467-72. PubMed ID: 9740612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenteric vascular smooth muscle cells from spontaneously hypertensive rats display increased calcium responses to angiotensin II but not to endothelin-1.
    Touyz RM; Tolloczko B; Schiffrin EL
    J Hypertens; 1994 Jun; 12(6):663-73. PubMed ID: 7963491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic angiotensin II type 1 receptor antagonism in genetic hypertension: effects on vascular structure and reactivity.
    Oddie CJ; Dilley RJ; Kanellakis P; Bobik A
    J Hypertens; 1993 Jul; 11(7):717-24. PubMed ID: 8228190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic in vivo inhibition of angiotensin-converting enzyme by perindopril in the endothelium and adventitia of large arteries and organs of the rabbit.
    Zhuo J; Casley D; Murone C; Mendelsohn FA
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):297-310. PubMed ID: 9125666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin II/prostaglandin I2 interactions in spontaneously hypertensive rats.
    Jackson EK; Herzer WA
    Hypertension; 1993 Nov; 22(5):688-98. PubMed ID: 8225529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal growth factor receptor is critical for angiotensin II-mediated hypertrophy in cerebral arterioles.
    Chan SL; Umesalma S; Baumbach GL
    Hypertension; 2015 Apr; 65(4):806-12. PubMed ID: 25733240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension.
    Hayakawa H; Raij L
    Hypertension; 1997 Jan; 29(1 Pt 2):235-41. PubMed ID: 9039108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinins or nitric oxide, or both, are involved in the antitrophic effects of angiotensin converting enzyme inhibitors on diabetes-associated mesenteric vascular hypertrophy in the rat.
    Rumble JR; Komers R; Cooper ME
    J Hypertens; 1996 May; 14(5):601-7. PubMed ID: 8762203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pivotal role of the renin-angiotensin system in Lyon hypertensive rats.
    Lantelme P; Lo M; Luttenauer L; Sassard J
    Am J Physiol; 1997 Nov; 273(5):R1793-9. PubMed ID: 9374825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remodelling of the vascular system in response to hypertension and drug therapy.
    Levy BI; Safar ME
    Clin Exp Pharmacol Physiol Suppl; 1992; 19():33-7. PubMed ID: 1395115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
    Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
    J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats.
    Matrougui K; Lévy BI; Henrion D
    Br J Pharmacol; 2000 Jun; 130(3):521-6. PubMed ID: 10821779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of antihypertensive drug therapy on vascular smooth muscle cell hypertrophy, hyperploidy, and hyperplasia in the spontaneously hypertensive rat.
    Owens GK
    Circ Res; 1985 Apr; 56(4):525-36. PubMed ID: 3978772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.
    Campbell DJ; Kladis A; Duncan AM
    Hypertension; 1994 Apr; 23(4):439-49. PubMed ID: 8144213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertension.
    Ishiguro K; Hayashi K; Sasamura H; Sakamaki Y; Itoh H
    Hypertension; 2009 Jan; 53(1):83-9. PubMed ID: 19047581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.